Home > Boards > Stock Clubs > Overvalued/Short Sellers > Probing stocks for shorts

Hit stop loss at 13.60

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Shannon_J_Sheffield Member Profile
Member Level 
Followed By 2
Posts 108
Boards Moderated 1
Alias Born 01/27/01
160x600 placeholder
Creatd Shares Gain 12% After Pricing Direct Offering
By Chris Wack
STOXX Europe 50 Index Ends 0.07% Higher at 3639.60 -- Data Talk
EURO STOXX 50 Index Ends Flat at 4188.31 -- Data Talk
STOXX Europe 600 Index Ends 0.07% Higher at 472.21 -- Data Talk
FTSE 100 Index Ends 0.25% Higher at 7222.82 -- Data Talk
DAX Ends 0.36% Higher at 15599.23 -- Data Talk
CAC 40 Index Ends 0.31% Lower at 6712.87 -- Data Talk
Home Depot on Track for Record High Close -- Data Talk
FTSE 100 Closes Up 0.3%, Driven by Miners
Linde Names Sanjiv Lamba as Chief Executive, Steve Angel Becomes Chairman -- Update
Avenue Therapeutics Shares Rise as FDA Panel to Meet on Appeal
Top Company News of the Day
Kimberly-Clark on Track for Lowest Close Since April 2020 -- Data Talk
Linde Names Sanjiv Lamba as New Chief Executive
Texas Factory Production Eased in October -- Dallas Fed
UBS to Sell Spanish Wealth-Management Business to Singular Bank
Tesla Up Nearly 7%, on Track for Record High Close -- Data Talk
Creatd Shares Rise 42% on Sale of Donald Trump Photos
Kimberly-Clark Expects FX to Boost Full-Year Sales -- Currency Comment
Bakkt Shares Rise 25% After Partnership With Mastercard
Belgium Business Confidence Stabilizes in October
Aurinia Pharmaceuticals Shares Rally on Report of Bristol Myers Interest
Moderna Says Interim Data Positive From Study of Covid-19 Vaccine in Children 6 to under 12
FTSE Gains, Potential BOE Rate Rise May Not Lift Sterling
U.S. Economic Growth Lost Further Momentum in September -- Chicago Fed
Hertz Orders 100,000 Teslas by End of 2022
Lennox International Sees Positive Forex Impact in Fiscal Year -- Currency Comment
Kimberly-Clark Lowers Full-Year Outlook Amid Higher Input Cost Inflation
Kimberly-Clark 3Q Earnings Squeezed Higher Input Costs
Citigroup Sees Significant Charges from Wind Down of South Korean Consumer Banking Business
Merck's Phase 3 Trials of HIV-1 Treatment Meet Primary Endpoint
Alkermes Gets Fast Track Designation for Ovarian Cancer Treatment
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences